Do hospital type or caseload make a difference in chemotherapy treatment patterns for early breast cancer? Results from 104 German institutions, 2008–2017

BACKGROUND: Over the past decade, chemotherapy has been used more selectively in early breast cancer (EBC) due to better risk stratification. Neoadjuvant chemotherapy (NACT) has evolved to the primary treatment option. The type and size of hospitals is known to have a substantial influence on the ki...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Breast
Egile Nagusiak: Riedel, Fabian, Hoffmann, Ann Sophie, Moderow, Mareike, Feisst, Manuel, Heublein, Sabine, Deutsch, Thomas Maximilian, Schäfgen, Benedikt, Golatta, Michael, Domschke, Christoph, Wallwiener, Markus, Heil, Jörg, Hennigs, André
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier 2021
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8102997/
https://ncbi.nlm.nih.gov/pubmed/33933924
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.breast.2021.04.006
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak